BioNTech | Website analytics by TrustRadar
Blurry colored background
biontech.de Biotechnology Pharmaceuticals Healthcare Research and Development

BioNTech

Wir führen Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.

BioNTech is a biotechnology company that focuses on developing personalized immunotherapies for the treatment of cancer and other serious diseases. The company utilizes its proprietary mRNA technology to create vaccines and therapies that are tailored to the genetic makeup of individual patients.

Unique Visits

360K

12000 / day

Total Views

450K

15000 / day

Visit Duration, avg.

3.8 min

3.2 pages per visit

Bounce Rate

42%

  • Domain Rating

  • Domain Authority

  • Citation Level

Founded in

2008

Supported Languages

English, etc

Website Key Features

mRNA Technology

BioNTech's proprietary mRNA technology is at the core of its therapeutic and vaccine development, enabling the creation of personalized treatments.

Cancer Immunotherapy

The company specializes in developing immunotherapies that harness the body's immune system to fight cancer.

Personalized Medicine

BioNTech's approach to medicine is highly personalized, aiming to tailor treatments to the genetic profile of each patient.

COVID-19 Vaccine

BioNTech, in partnership with Pfizer, developed one of the first mRNA-based COVID-19 vaccines, demonstrating the potential of its technology in addressing global health crises.

Research Collaborations

The company engages in numerous research collaborations with academic institutions, pharmaceutical companies, and other biotechnology firms to advance its therapeutic and vaccine development.

Additional information

Headquarters

Mainz, Germany

Key People

Ugur Sahin (CEO), Özlem Türeci (CMO)

Number of Employees

Over 1,800 (as of 2021)

Stock Symbol

NASDAQ: BNTX

Notable Achievements

Development of the first mRNA-based COVID-19 vaccine in partnership with Pfizer.

Future Directions

BioNTech continues to explore the application of its mRNA technology in vaccines for other infectious diseases and in the development of novel cancer immunotherapies.

HTTP headers

Security headers report is a very important part of user data protection. Learn more about http headers for biontech.de